Related Experiment Video
Updated: Apr 21, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma
Paulisally Hau Yi Lo1, Chizu Tanikawa1, Toyomasa Katagiri2
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Abstract:
Development of cancer is a complex process involving multiple genetic and epigenetic alterations. In our microarray analysis of 81 breast carcinoma specimens, we identified peptidase domain containing associated with muscle regeneration 1 (PAMR1) as being frequently suppressed in breast cancer tissues. PAMR1 expression was also reduced in all tested breast cancer cell lines, while PAMR1 was expressed moderately in normal breast tissues and primary mammary epithelial cells. DNA sequencing of the PAMR1 promoter after sodium bisulfite treatment revealed that CpG sites were hypermethylated in the breast cancer tissues and cell lines. PAMR1 expression was restored by 5-aza-2' deoxycytidine treatment, demonstrating that promoter hypermethylation contributed to PAMR1 inactivation in the breast cancer cells. In addition, ectopic expression of PAMR1 markedly suppressed cancer cell growth. In summary, our study identified PAMR1 as a putative tumor suppressor which was frequently inactivated by promoter hypermethylation in breast cancer tissues.
Insights
Peptidase domain containing associated with muscle regeneration 1 (PAMR1) is suppressed in breast cancer due to promoter hypermethylation. Restoring PAMR1 expression inhibited cancer cell growth, identifying it as a potential tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Cancer development involves genetic and epigenetic changes.
- Peptidase domain containing associated with muscle regeneration 1 (PAMR1) role in breast cancer is largely unknown.
Purpose of the Study:
- To investigate the role of PAMR1 in breast cancer.
- To determine the mechanism of PAMR1 regulation in breast cancer.
Main Methods:
- Microarray analysis of 81 breast carcinoma specimens.
- DNA sequencing of the PAMR1 promoter.
- Treatment with 5-aza-2' deoxycytidine.
- Ectopic expression of PAMR1 in cancer cells.
Main Results:
- PAMR1 was frequently suppressed in breast cancer tissues and cell lines.
- PAMR1 promoter was hypermethylated in breast cancer specimens.
- 5-aza-2' deoxycytidine treatment restored PAMR1 expression.
- Ectopic PAMR1 expression suppressed cancer cell growth.
Conclusions:
- PAMR1 acts as a tumor suppressor in breast cancer.
- Promoter hypermethylation is a key mechanism for PAMR1 inactivation.
- PAMR1 is a potential therapeutic target for breast cancer.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

